THY1 and hepatocellular carcinoma: The result showed that CDDP treatment increased the mean percentage of CD90+ cells to 5.8-fold that of the control PBS treatment among HepG2 cells (Figure 2C), and the chemosensitivity of HCC stem cells decreased, causing the cells to be enriched.